Clinical Trials Browser

Interventional × Tinzaparin × Classical hematology × Clear all

Thrombocytopenia

NCT01130025 2025-02-24

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Phase 3 Completed

900 enrolled

Classical hematology

Venous Thromboembolism

NCT03090880 2022-11-17

PROVE

Phase 3 Terminated

59 enrolled

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Phase 3 Unknown

99 enrolled

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT01817257 2018-10-29

ALICAT

Phase 2 Terminated

2 enrolled

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT00981903 2017-07-06

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Phase 2 Terminated

131 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

Phase 3 Terminated

56 enrolled

Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00629447 2013-01-07

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Phase NA Completed

40 enrolled

CNSClassical hematology

Brain Neoplasms, Venous Thromboembolism

Clinical Trials

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

PROVE

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

ALICAT

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Longheva

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients